Korro Bio Inc KRRO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
54.66UNCH (UNCH)
Volume
934
Close
54.66quote price arrow up+3.40 (+6.63%)
Volume
59,857
52 week range
9.15 - 97.91
Loading...
  • Open51.17
  • Day High54.97
  • Day Low50.98
  • Prev Close51.26
  • 52 Week High97.91
  • 52 Week High Date03/27/24
  • 52 Week Low9.15
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap506.862M
  • Shares Out9.27M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change14.04

KEY STATS

  • Open51.17
  • Day High54.97
  • Day Low50.98
  • Prev Close51.26
  • 52 Week High97.91
  • 52 Week High Date03/27/24
  • 52 Week Low9.15
  • 52 Week Low Date10/30/23
  • Market Cap506.862M
  • Shares Out9.27M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change14.04

RATIOS/PROFITABILITY

  • EPS (TTM)-43.16
  • P/E (TTM)-1.27
  • Fwd P/E (NTM)-5.52
  • EBITDA (TTM)-82.12M
  • ROE (TTM)-79.36%
  • Revenue (TTM)-
  • Gross Margin (TTM)31.89%
  • Net Margin (TTM)-931.26%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Korro Bio Inc

 

Profile

MORE
Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic...
Nessan Bermingham Ph.D.
Chairman of the Board, Co-Founder
Ram Aiyar Ph.D.
President, Chief Executive Officer, Director
Todd Chappell
Chief Operating Officer
Vineet Agarwal
Chief Financial Officer, Principal Accounting Officer, Treasurer, Principal Financial Officer
Address
One Kendall Square. Building 600-700
Suite 6-401
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
ALLO
Allogene Therapeutics Inc
2.77-0.24-7.97%
SLRN
ACELYRIN Inc
4.39-0.24-5.18%
THRD
Third Harmonic Bio Inc
13.87-0.37-2.57%
CRBP
Corbus Pharmaceuticals Holdings Inc
45.00-0.92-2.00%
LRMR
Larimar Therapeutics Inc
7.38-0.05-0.67%